Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Abstract 6938: Body Mass Index, LDL-Cholesterol Response, and Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome

Introduction: Obesity and overweight characterize many patients with acute coronary syndrome (ACS). In the ODYSSEY OUTCOMES trial, alirocumab reduced major adverse cardiovascular events (MACE) post-ACS compared with placebo, with protocol-driven dose up-titration from 75 to 150 mg to achieve target LDL-cholesterol (...

G. Schwartz, H. Tavori, Xin Zheng et al. · 0 citations
Oct 2026

Left Atrial Appendage Closure in Atrial Fibrillation Patients With High Risk of Stroke and Bleeding: An Individual Participant Data Meta-Analysis of Randomized Trials.

BACKGROUND Percutaneous left atrial appendage closure (LAAC) is increasingly used as an alternative to oral anticoagulation for stroke prevention in atrial fibrillation. Its comparative effectiveness and safety in patients at a high risk of both stroke and bleeding remain uncertain. OBJECTIVES We evaluated the effica...

C. Skurk, I. Eitel, T. Thevathasan et al. · 3 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.